PHATHOM PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $0 | — |
| FY2018 | — | $-1.3M | $879.0K |
| FY2019 | $22.8M | $228.0M | $243.8M |
| FY2020 | $39.6M | $194.3M | $287.5M |
| FY2021 | $89.7M | $72.2M | $183.3M |
| FY2022 | $95.3M | $-74.8M | $155.4M |
| FY2023 | $137.8M | $-72.8M | $381.4M |
| FY2024 | $201.4M | $-253.6M | $297.3M |
| FY2025 | $209.1M | $-438.2M | $130.0M |